ADVANT Nctm
ADVANT Nctm assists the full range of actors in the healthcare and life sciences sector, from manufacturers and pharmaceutical companies to regulators, investors and public-private partnerships. The firm draws talent from across departments to cater to each matter, be it IP, anti-trust or administrative. The two heads of the healthcare and life sciences practice are Lorena Possagno, who focuses on corporate and commercial assistance, and Paolo Gallarati, who specialises in international transactions and compliance in life sciences. In 2023, both Jacopo Arnaboldi and Giulio Uras were promoted to partner.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘The team is professional and responsive. They put client's interest as top priority in negotiations.’
‘The partner Lorena Possagno plays a critical role in projects and helps non-EU client understand EU listing regulations.’
‘Extremely supportive, professional, dynamic and decisive team.’
‘A really professional team. No matter what problem you have, there is always the right lawyer to talk to and drill into issues to get solutions.’
‘Lorena Possagno is very professional and with the first target to not have a dispute but to reach a compromise.’
‘Committed to clients success.’
‘Advant Nctm team is pragmatic, efficient and really problem solving oriented. The team is also very proactive and knows very well the the different industries/sectors.’
‘Lorena Possagno is an exceptional negotiator and communicator.’
Key clients
- Astrazeneca S.p.A.
- Fresenius Group
- Gilead Sciences S.r.l.
- Doc Generici S.r.l.
- Genetic S.p.A.
- Aboca
- Allovir Inc.
- Circassia Pharmaceuticals Ltd
- Uriach Italy
- Opocrin S.p.A.
- Astrazeneca S.p.A.
- Ream SGR S.p.A.
- Gilead Sciences S.r.l.
- Doc Generici S.r.l.
- Genetic S.p.A.
- Advanced Medtech
Work highlights
- Assisting Fresenius Group in relation to a wide array of legal services, such as a) dealing with AIFA and Public Administration; b) IP issues/intellectual property protection; c) legal issues related to compliance topics; d) legal issues related to employment agreements and labour topics; and e) corporate governance.
- Assisted Mediolanum Farmaceutici in relation to the sale of an undisclosed percetange of Neopharmed Gentili, another Italian pharmaceutical company owned also by French Private Equity fund Ardiani and by Del Bono family to the Luxembourg Private Equity fund NB Renaissance. Value: EUR 1,5 billion.
- Assisting AstraZeneca S.p.A. in relation to data protection matters.
Practice head
The lawyer(s) leading their teams.
Lorena Possagno, Paolo Gallarati